Drugmaker Catalent plans to develop a $40 million testing facility in North Carolina, the latest life science company to expand in the state’s Research Triangle region.
Drugmaker Catalent plans to develop a $40 million testing facility in North Carolina, the latest life science company to expand in the state’s Research Triangle region.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
1300 Patterson Dr, Bloomington, IN
Manufacturing